Ethiopia reports suspected viral haemorrhagic fever outbreak
On Nov. 13, 2025, the World Health Organization (WHO) reported that Health authorities in Ethiopia are carrying out…
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
On Nov. 13, 2025, Legend Biotech announced the official opening and ribbon cutting of its new, state-of-the-art research…
New Jersey man’s death first one to be tied to tick-related meat allergy
On Nov. 13, 2025, a previously healthy New Jersey man has been identified by an allergist at the…
FDA Quietly Approves Denosumab Biosimilars, Issues Interchangeability for Others
On Nov. 13, 2025, the U.S. Food and Drug Administration (FDA) approved multiple denosumab biosimilars, enhancing market access…
New DNA Test to Track Leishmaniasis Infections
On Nov. 12, 2025, a study led by the Hebrew University of Jerusalem, and the Laboratory of Entomology…
Scientists unveil the world’s most comprehensive AI-powered tool for neuroscience: Brain Knowledge Platform
On Nov. 12, 2025, Allen Institute researchers and engineers have unlocked an the world’s most comprehensive AI-powered tool…
Researchers pioneer greener way to extract rare earth elements
On Nov. 12, 2025, a team of University of California, Berkeley-led researchers reported in Nano Letters that they…
Biotechnology | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine | Women's Health
Stanford Medicine scientists tie lupus to a virus nearly all of us carry
On Nov. 12, 2025, Stanford Medicine scientists have found that the Epstein-Barr virus can convert B cells it’s…
RSV vaccine highly effective against hospital admission in older adults, study suggests
On Nov. 12, 2025, UK researchers reported a test-negative, case-control study across 14 hospitals in England finds that the…
Animal testing to be phased out faster as UK unveils roadmap for alternative methods
On Nov. 11, 2025, the United Kingdom government announced that animal testing in science is set to be…
Artificial Intelligence | Biotechnology | Energy | Environmental | Forestry | Genomics | Infectious Disease | Nanotechnology | Neurology | Oncology | Pharmaceutical | Therapeutics | Vaccine
China’s new scientist visa is a ‘serious bid’ for the world’s top talent
On Nov. 11, 2025, China introduced a visa that will allow young foreign researchers in science, technology, engineering…
Existing evidence does not clearly link paracetamol use during pregnancy with autism or ADHD in children
On Nov. 10, 2025, a study led by the University of Liverpool reported that existing evidence does not…
Biotechnology | CDC | COVID-19 | Infectious Disease | Measles | Vaccine
Canada Loses Measles Elimination status after three decades
On Nov. 10, 2025, Canada has lost its measles elimination status after nearly three decades due to its…
FDA reverses decades-old warning on hormone therapy products for menopause
On Nov. 10, 2025, the Food and Drug Administration (FDA) is reversing a 2003 decision that put a…
Life Found in a Place Scientists Though Impossible
On Nov. 9, 2025, scientists from the Center for Marine Environmental Sciences, University of Bremen reported they had…
Texas A&M deputy chemistry chair Fang Lei joins $3.6 billion Chinese lab
On Nov. 7, 2025, Fang Lei, Ph.D., a long-time professor with Texas A&M University’s chemistry department, has returned…
Women are three times more likely than men to get severe long COVID
On Nov. 7, 2025, research published today in Cell Reports Medicine reveals key biological differences that may explain why…
Despite global decrease, Chagas disease is rising in non-endemic regions
On Nov. 6, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
WHO publishes new global research agenda to strengthen paediatric clinical trials
On Nov. 6, 2025, the World Health Organization (WHO) released a technical report, The future of paediatric clinical trials…
Biotechnology | FDA | Medicine | Therapeutics
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans
On Nov. 6, 2025, Eli Lilly announced an agreement with the U.S. government to expand access to its…
Oxford scientists capture genome’s structure in unprecedented detail
On Nov. 6, 2025, scientists from Oxford’s Radcliffe Department of Medicine have achieved the most detailed view yet…
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
On Nov. 6, 2025, Novo Nordisk announced it has agreed with the U.S. Administration to lower drug prices…
Steady glucose-monitor use helps blood-sugar control
On Nov. 5, 2025, a large study of adults with type 2 diabetes showed that those who consistently…
Successful bone regeneration using stem cells derived from fatty tissue
On Nov. 5, 2025, an Osaka Metropolitan University team has used stem cells extracted from adipose, the body’s…
‘Mind-captioning’ AI decodes brain activity to turn thoughts into text
On Nov. 5, 2025, researchers announced that reading a person’s mind using a recording of their brain activity…
MIT researchers invent new human brain model to enable disease research, drug discovery
On Nov. 5, 2025, MIT researchers announced they have developed a new 3D human brain tissue platform, the…
WHO Reports Rift Valley fever in Mauritania and Senegal
On Nov. 5, 2025, the World Health Organization (WHO) reported that between 20 September and 30 October 2025,…
Colossal Biosciences Acquires Viagen, the Leader in Animal Cloning
On Nov. 4, 2025, Colossal Biosciences, the world’s de-extinction company, today announced its acquisition of Viagen Pets and…
Biotechnology | Diagnostics | Environmental | Forestry | Genomics | Marine Science | Non-Profit Research
Once thought a fantasy, effort to sequence DNA of millions of species gains momentum
On Nov. 4, 2025, six years ago this month, scientists launched a massively ambitious effort to sequence the…
Biotechnology | Disease | FDA | Therapeutics
FDA approves menin inhibitor for patients with acute leukemia with NPM1 mutation, backed by Dana-Farber science
On Nov. 4, 2025, the U.S. Food and Drug Administration (FDA) approved revumenib, a first-in-class oral menin inhibitor,…